Cardiovascular prevention in the over-80 age group is not beneficial
de Ruijter, W.; Gussekloo, J.
Nederlands Tijdschrift Voor Geneeskunde 152(1): 27
2008
ISSN/ISBN: 0028-2162 PMID: 18240758 Document Number: 620469
The high prevalence and incidence of cardiovascular disease in the oldest old justify consideration of both primary and secondary prevention measures in this age group. However, evidence for the effectiveness of any preventive intervention is lacking. Regarding primary prevention, it is also unknown which elderly are actually at risk of developing new cardiovascular disease.
Document emailed within 1 workday
Related Documents
Gysling, E. 1995: Cardiovascular pharmacotherapy in old age: how beneficial is it? what does it cost? Praxis 84(44): 1248-12511999: Canadian Cardiovascular Society 1998 Consensus Conference on the Prevention of Cardiovascular Diseases: The Role of the Cardiovascular Specialist Canadian Journal of Cardiology 15 Suppl G: 1g
De Caterina, R. 2001: The Primary Prevention Project Study Group. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice Italian Heart Journal. Supplement: Official Journal of the Italian Federation of Cardiology 2(6): 681-684
Metelitsa, V.I.; Ostrovskaia, T.P.; Duda, S.G.; Filatova, N.P.; Vygodin, V.A.; Mukhamedzhanova, G.F. 1994: The basic antihypertensive drugs for the long-term secondary prevention of cardiovascular diseases (the working group of the multicenter study Captopril and the Quality of Life) Terapevticheskii Arkhiv 66(9): 78-82
Viberti, G.C. 2003: Rosiglitazone: potential beneficial impact on cardiovascular disease International Journal of Clinical Practice 57(2): 128-134
Van Gaal, L.F.; Wauters, M.A.; De Leeuw, I.H. 1997: The beneficial effects of modest weight loss on cardiovascular risk factors International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 21(Suppl 1): S5-S9
Von Bibra, H.; Fehske, W. 1999: Reports of the German Society of Cardiology-Heart and Cardiovascular Research. Report of activities of the Cardiovascular Ultrasound Study Group 1998/99 Zeitschrift für Kardiologie 88(10): 880-882
Patton, M.L.; Gurll, N.J.; Reynolds, D.G.; Vargish, T. 1983: Adrenalectomy abolishes and cortisol restores naloxone's beneficial effects on cardiovascular function and survival in canine hemorrhagic shock Circulatory Shock 10(4): 317-327
Bates, T. 1994: Social Resources Generated by Group Support Networks May Not Be Beneficial to Asian Immigrant-Owned Small Businesses Social Forces 72(3): 671-689
Makar, O.; Siabrenko, G. 2018: Influence of Physical Activity on Cardiovascular System and Prevention of Cardiovascular Diseases (Review) Georgian Medical News 2018(285): 69-74
Chopeĭ, I.V.; Rosul, M.M.; Hechko, M.M.; Chubirko, K.I.; Korabel'shchykova, M.O.; Ivan'o, N.V. 2014: Cardiovascular continuum: the role of the family doctor in prevention of cardiovascular diseases Wiadomosci Lekarskie 67(2 Pt 2): 243-247
Björnstig, U. 1999: Accident prevention has been beneficial. A historical reflection and current update Lakartidningen 96(3): 182-187
Lowe, G.; Rumley, A.; Norrie, J.; Ford, I.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Packard, C. 2000: Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study Thrombosis and Haemostasis 84(4): 553-558
Farský, Štefan.; Rus, V.; Sládeková, K.ína. 2018: How to apply the ambulatory cardiovascular rehabilitation: guidelines of the Working group for cardiovascular rehabilitation at Slovak Society of Cardiology Vnitrni lekarstvi 63(12): 972-979
Leone, O.; Agozzino, L.; Angelini, A.; Bartoloni, G.; Basso, C.; Caruso, G.; D'Amati, G.; Pucci, A.; Thiene, G.; Gallo, P. 2012: Criteria for histopathologic diagnosis of aortic disease consensus statement from the SIAPEC-IAP study group of "cardiovascular pathology" in collaboration with the association for Italian cardiovascular pathology Pathologica 104(1): 1-33
Gordin, F.; Chaisson, R.E.; Matts, J.P.; Miller, C.; de Lourdes Garcia, M.; Hafner, R.; Valdespino, J.L.; Coberly, J.; Schechter, M.; Klukowicz, A.J.; Barry, M.A.; O'Brien, R.J. 2000: Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group JAMA 283(11): 1445-1450
Huo, Y.; Li, X.Y. 2018: Deepen our thoughts on the prevention of cardiovascular disease and actively contribute to the earlier appearance of the turning point noting the reduced prevalence of cardiovascular diseases Zhonghua Xin Xue Guan Bing Za Zhi 46(1): 3-6
Yonekura, S.; Okamoto, Y.; Okubo, K.; Okawa, T.; Gotoh, M.; Suzuki, H.; Kakuma, T.; Horiguchi, S.; Hanazawa, T.; Konno, A.; Okuda, M. 2009: Beneficial effects of leukotriene receptor antagonists in the prevention of cedar pollinosis in a community setting Journal of Investigational Allergology and Clinical Immunology 19(3): 195-203
Breckenkamp, J.; Laaser, U.; Meyer, S. 1995: The German Cardiovascular Prevention Study: social gradient for the net effects in prevention of hypercholesterolemia Zeitschrift für Kardiologie 84(9): 694-699
Kleinert, S. 1999: HOPE for cardiovascular disease prevention with ACE-inhibitor ramipril. Heart Outcomes Prevention Evaluation Lancet 354(9181): 841